3 Top Biotech Stocks to Buy in March
Biotech stocks have had a rough few weeks. These seemingly unstoppable stocks have followed the market in a sell-off that has some investors struggling to sit still. For instance, the iShares Biotech Nasdaq ETF slipped more than 9% over the past month. Even some players that soared to all-time highs or posted four-digit percentage gains last year have slipped.
But this decline might actually represent an opportunity. Investors are now able to snatch up some stocks at pre-pandemic price levels. Let's check out three biotech stocks that each have dropped more than 28% so far from their most recent high points.
Image source: Getty Images.
Source Fool.com
